Head-to-head · The Match Score
CoreAge Rx vs Ro
Both scored on the same six-factor Match Score. CoreAge Rx wins this matchup with a 91 to 74 edge.
CoreAge Rx
Grade A−
People who want one flat monthly price on either molecule that doesn't climb as the dose goes up, and who don't need a brand-name drug or a pill.
Visit CoreAge RxRo
Grade C
Anyone who wants FDA-approved Wegovy or Zepbound and help getting insurance to pay for it.
Visit RoFactor by factor
The six sub-scores behind each Match Score. The quiz reweights these to your priorities — one provider can pull ahead for you on the factors you care about.
Price, coverage & formulary
| Detail | CoreAge Rx | Ro |
|---|---|---|
| Semaglutide | $99/mo at every dose | $348/mo (starting dose, all-in with the membership, brand-name) |
| Tirzepatide | $149/mo at every dose | $448/mo (starting dose, all-in with the membership, brand-name) |
| Coverage | U.S. only — restrictions vary by state and therapy, list not published | Coverage not published |
| Brand-name access | Not listed | Yes |
| Oral / sublingual | Not listed | Yes |
| Match Score | 91 · A− | 74 · C |
CoreAge Rx edges out Ro, 91 to 74 on the default Match Score. Compounded semaglutide at $99 and tirzepatide at $149 a month, the same price at every dose, with no membership fee and a full refund if the doctor doesn't approve you.
Ro is still a fair pick if its strengths line up with yours — best for: Anyone who wants FDA-approved Wegovy or Zepbound and help getting insurance to pay for it.
Assume any provider we list may compensate us, at no cost to you. It never changes the Match Score.
More head-to-heads
Or browse alternatives to CoreAge Rx and all comparisons.
Pricing, states and verification reflect each provider's public disclosures at last review; the Match Score and its sub-scores are our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.